; (B) provide training and technical assistance to States, localities, and Indian tribes for purposes of carrying out such activity; and (C) award grants to States, localities, and Indian tribes for purposes of carrying out such activity. (2) Evidence-based prevention activities An evidence-based prevention activity described in this paragraph is any of the following activities: (A) Improving the efficiency and use of a new or currently operating prescription drug monitoring program, including by— (i) encouraging all authorized users (as specified by the State or other entity) to register with and use the program; (ii) enabling such users to access any updates to information collected by the program in as close to real-time as possible; (iii) improving the ease of use of such program; (iv) providing for a mechanism for the program to notify authorized users of any potential misuse or abuse of controlled substances and any detection of inappropriate prescribing or dispensing practices relating to such substances; (v) encouraging the analysis of prescription drug monitoring data for purposes of providing de-identified, aggregate reports based on such analysis to State public health agencies, State substance abuse agencies, State licensing boards, and other appropriate State agencies, as permitted under applicable Federal and State law and the policies of the prescription drug monitoring program and not containing any protected health information, to prevent inappropriate prescribing, drug diversion, or abuse and misuse of controlled substances, and to facilitate better coordination among agencies; (vi) enhancing interoperability between the program and any health information technology (including certified health information technology), including by integrating program data into such technology; (vii) updating program capabilities to respond to technological innovation for purposes of appropriately addressing the occurrence and evolution of controlled substance overdoses